|
Neo-polycinDrug - Neo-polycin The trade name of the product as shown on the labeling.
Dosage -
SOLUTION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate
Strength -
0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
Applicant -
DOW PHARM
New Drug Application (NDA) Number -
060427
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Dow Pharmaceutical Corp Sub Dow Chemical Co
Neo-polycin
Neomycin Sulfate And Polymyxin B Sulfate Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic
Neo-polycin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic Follutein 10,000 Units/vial Injectable; Injection Pregnyl 10,000 Units/vial Injectable; Injection Zoladex Eq 10.8mg Base Implant; Implantation Zoladex Eq 3.6mg Base Implant; Implantation Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic Neomycin And Polymyxin B Sulfates And Gramicidin 0.025mg/ml;eq 1.75mg Base/ml;10,000 Units/ml Solution/drops; Ophthalmic NewDrugInformation |